Thus, we were able to conclude that STEAP2 inhibition is likely to reduce the proliferation, clonogenicity, infiltration, and migration of osteosarcoma cells, while its overexpression is likely to facilitate all of these outcomes. This evidence concerns the gene STEAP2 and osteosarcoma.